eCommons@AKU
Department of Pathology and Laboratory Medicine

Medical College, Pakistan

February 2018

Human west nile virus disease outbreak in Pakistan,
2015–2016
E. Khan
Aga Khan University, erum.khan@aku.edu

Kelli L. Barr
University of Florida

Joveria Farooqi
Aga Khan University, joveria.farooqi@aku.edu

Dhani Prakoso
University of Florida

Alizae Abbas
Aga Khan University
See next page for additional authors

Follow this and additional works at: https://ecommons.aku.edu/
pakistan_fhs_mc_pathol_microbiol
Part of the Pathology Commons
Recommended Citation
Khan, E., Barr, K. L., Farooqi, J., Prakoso, D., Abbas, A., Khan, Z. Y., Ashi, S., Imtiaz, K., Aziz, Z., Malik, F. (2018). Human west nile
virus disease outbreak in Pakistan, 2015–2016. Frontiers in public health, 6(20).
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol/711

Authors

E. Khan, Kelli L. Barr, Joveria Farooqi, Dhani Prakoso, Alizae Abbas, Zain Y. Khan, Shanze Ashi, Kehkashan
Imtiaz, Z Aziz, and Faisal Malik

This article is available at eCommons@AKU: https://ecommons.aku.edu/pakistan_fhs_mc_pathol_microbiol/711

Original Research
published: 27 February 2018
doi: 10.3389/fpubh.2018.00020

H
Erum Khan1, Kelli L. Barr2*, Joveria Qais Farooqi1, Dhani Prakoso2, Alizae Abbas1,
Zain Y. Khan1, Shanze Ashi1, Kehkashan Imtiaz1, Z. Aziz1, Faisal Malik1, John A. Lednicky3
and Maureen T. Long2
1
Department of Pathology and Laboratory Medicine, Aga Khan University, Karachi, Pakistan, 2 Department of Comparative
Diagnostic and Population Medicine, College of Veterinary Medicine, University of Florida, Gainesville, FL, United States,
3
Department of Environmental and Global Health, Emerging Pathogens Institute, University of Florida, Gainesville, FL,
United States

Edited by:
Nicola Petrosillo,
Istituto Nazionale per le Malattie
Infettive Lazzaro Spallanzani (IRCCS),
Italy
Reviewed by:
Evandro R. Winkelmann,
Columbia University, United States
Lorenzo Zammarchi,
University of Florence, Italy
*Correspondence:
Kelli L. Barr
kellilbarr@ufl.edu
Specialty section:
This article was submitted to
Infectious Diseases – Surveillance,
Prevention and Treatment,
a section of the journal
Frontiers in Public Health
Received: 20 November 2017
Accepted: 22 January 2018
Published: 27 February 2018
Citation:
Khan E, Barr KL, Farooqi JQ,
Prakoso D, Abbas A, Khan ZY,
Ashi S, Imtiaz K, Aziz Z, Malik F,
Lednicky JA and Long MT (2018)
Human West Nile Virus Disease
Outbreak in Pakistan, 2015–2016.
Front. Public Health 6:20.
doi: 10.3389/fpubh.2018.00020

Like most of the world, Pakistan has seen an increase in mosquito-transmitted diseases
in recent years. The magnitude and distribution of these diseases are poorly understood
as Pakistan does not have a nation-wide system for reporting disease. A cross-sectional
study to determine which flaviviruses were causing of arboviral disease in Pakistan was
instituted. West Nile virus (WNV) is a cause of seasonal fever with neurotropic findings in
countries that share borders with Pakistan. Here, we describe the active and persistent
circulation of WNV in humans in the southern region of Pakistan. This is the first report
of WNV causing neurological disease in human patients in this country. Of 997 enrolled
patients presenting with clinical features suggestive of arboviral disease, 105 were
positive for WNV IgM antibodies, and 71 of these patients possessed WNV-specific
neutralizing antibodies. Cross-reactivity of WNV IgM antibodies with Japanese encephalitis virus (JEV) occurred in 75 of these 105 patients. WNV co-infections with Dengue
viruses were not a contributing factor for the severity of disease. Nor did prior exposure
to dengue virus contribute to incidence of neurological involvement in WNV-infected
patients. Patients with WNV infections were more likely to present with altered mental
status, seizures, and reduced Glasgow Coma scores when compared with JEV-infected
patients. Human WNV cases and vector numbers exhibited a temporal correlation with
climate.
Keywords: West Nile virus, Dengue virus, Japanese encephalitis virus, encephalitis, arboviral disease

INTRODUCTION
West Nile virus (WNV) is a single-stranded, enveloped positive-sense RNA flavivirus that is maintained in nature by an enzootic cycle between birds and blood-feeding Culex mosquitoes (family
Culicidae) (1). Culex spp. are widely distributed over the world and have been reported to feed on
birds, humans, horses, and other mammals (2). Outbreaks of WNV disease have been reported
in Europe, America, Africa, and parts of Asia (3–5). Serological evidence in humans and vector
competence for WNV in Pakistan has been reported as early as 1982 (6, 7). In recent years, WNV has
been identified in horses and humans in Pakistan and its neighboring countries, Iran, Afghanistan,
and India as a cause of human encephalitic disease (8–13). Surveillance studies in these surrounding
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countries report WNV circulation in several Culex species as well
as several wild, migratory, and domestic birds and water fowl
(14–19).
With the dissolution of the Pakistan Federal Ministry of
Health in 2011, reporting and surveillance for arboviral diseases
have become largely non-existent and, when performed, is
highly localized and mostly funded by foreign granting agencies. Pakistan is at a continual risk of suffering large epidemics
of vector-borne diseases for a variety of reasons. Geopolitical
instability, annual flooding, and poor health care infrastructure
lead to frequent internal human and animal displacement.
Moreover, the construction of super highways and shipping ports
for efficient travel between Africa and China has left Pakistan
vulnerable to the introduction of foreign diseases. Pakistan has
recently witnessed an increased burden of arboviral infections,
primarily from Crimean-Congo hemorrhagic fever virus, WNV,
Chikungunya virus (CHIKV), and Dengue viruses (DENVs)
affecting the economic, social, and political aspects of people’s
lives (7, 20–22). More recently, active circulation of DENV, WNV,
and CHIKV has been reported in humans living in the Punjab
province of Pakistan (22).
Pakistan lacks a holistic surveillance system for arbovirus
infections; therefore, there are limited data regarding types of
vectors circulating, their temporal trends, and their correlations
with climatic factors and human/animal cases. In light of the
heightened alert of epidemic outbreaks and the global spread of
arboviruses like WNV, CHIKV, and Zika virus, active surveillance
for arboviruses in Pakistan is desperately needed for effective
implementation of preventive and control strategies. Here, we
present results of a multiyear seroprevalence and mosquito surveillance project initiated in 2015 that analyzed human arboviral
exposure, mosquito vectors, and their correlation with climatic
factors.

Figure 1 | Locations of the patient enrollment sites in the Sindh region of
Pakistan (8). Sites included medical colleges, teaching hospitals, and civil
hospitals.

Five study sites were established, and personnel were trained
throughout the Sindh province in Pakistan (Figure 1) (8). These
sites included medical colleges, teaching hospitals, and civil
hospitals.

Diagnostic Criteria

Patients were confirmed positive for virus exposure according to
CDC criteria, which requires “virus-specific IgM antibodies in
serum with confirmatory virus-specific neutralizing antibodies
in the same or a later specimen” (23). Patients were classified as
a suspect case if they had virus-specific IgM antibodies in serum
but with a neutralizing titer of less than 50% at the highest concentration of serum. For cross-reactive specimens, patients were
confirmed positive when they had virus-specific IgM antibodies
and neutralizing antibodies in the same specimen that exhibited
the highest level of neutralization for one of the viruses in question. Cross-reactive patients were classified as suspect according
to the greatest amount of virus-specific IgM antibodies. Patients
were considered positive for DENV co-infection if they had
DENV-specific NS1 antigen. Patients were considered as having
prior DENV exposure if they exhibited greater than 80% neutralization at the 1:2560 serum dilution.

MATERIALS AND METHODS
Patient Enrollment

A cross-sectional, observational study was performed to identify
which arboviruses [DENV, WNV, and Japanese encephalitis virus
(JEV)] were the cause of acute undifferentiated febrile illness in
selected basic health units and/or district hospitals of the Sindh
region of Pakistan (8). Patients were enrolled under informed
consent procedures, which were reviewed and approved by the
Ethics Review Committee at Aga Khan University (3183-PATERC-14) and the Institutional Review Board at the University of
Florida (201500908). All enrolled subjects gave written informed
consent in accordance with the Declaration of Helsinki. Patients
presenting with the CDC clinical description of arboviral disease including findings of rash, headache, arthralgia, myalgia,
gastrointestinal distress, acute hemorrhagic fever, acute flaccid
paralysis, encephalitis, meningitis, and/or unexplained fever
were recruited (23). Patients younger than 10 years and older
than 90 years were excluded. Briefly, all patients were tested
for DENV NS1 antigen unless affected primarily by neurologic
abnormalities. All NS1-negative sera were evaluated for exposure to WNV or JEV via IgM capture ELISA for JEV and WNV.
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NS1 and IgM ELISA Testing for
Flaviviruses

Primary DENV screening in patients was performed using
a commercial ELISA (Panbio Dengue Early Rapid Test NS1
antigen capture test, Alere, Waltham, MA, USA) following
manufacturer’s instructions. For WNV and JEV, a commercial
IgM capture ELISA for work with diagnostic specimens in BSL-2
facilities (InBios WNV Detect™ and JEV Detect™, InBios,
Seattle, WA, USA) was used following the manufacturer’s
instructions.
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RT-PCR

continuity of data. Four-fold dilutions of heat-inactivated patient
serum were mixed with an equal volume of MEM (Corning,
Tewksbury, MA, USA) containing ~50–100 plaque-forming
units of virus and incubated for 1 h at 37°C. After incubation,
this mixture was inoculated onto confluent Vero E6 cells in
12-well plates, which were then incubated for 1 h at 37°C. After
incubation, the inoculum was removed; and an overlay of MEM
with 0.5% wt/vol methylcellulose, 2.5% FBS, non-essential amino
acids, penicillin, streptomycin, and amphotericin B was added to
the wells; and the plates were incubated until plaques were visible
(3–10 days). For visualization of plaques, the methylcellulose
overlay was removed, and cells were stained with a fresh mixture
of 50% methanol, 43% ethanol, 7% acetic acid, and 0.1% wt/vol
Comassie blue and plaques were counted. The antibody titer was
determined as the highest serum dilution that neutralized 50% of
the virus inoculum.

West Nile virus and JEV primers and probes were used to detect
the NS2 gene (24). The samples of all WNV and/or JEV IgMpositive samples and mosquito pools were screened. Briefly, RNA
was isolated from mosquito pools, human CSF (where received,
patients with neurological symptoms only), and serum samples
using a commercial virus RNA extraction kit (QIAamp viral RNA
kit, Qiagen, Valencia, CA, USA). Mosquito pools were homogenized in PBS to form a 1:10 (v/v) homogenate using sterile
pestles in 1.5-ml polypropylene tubes. All samples were stored
at −80°C until use.
RNA was reverse transcribed to cDNA (iScript cDNA
Synthesis Kit, Bio-Rad, Hercules, CA, USA), and PCR was performed. For the WNV PCR, 1,000 nM of forward and reverse
primers and 200 nM of fluorogenic probe were used, and for the
JEV PCR, 375 nM of forward and reverse primers and 250 nM of
fluorogenic probe were used (Biosearch Technologies, Petaluma,
CA, USA) in a 20-µl total reaction volume. Standard cycling
conditions consisted of once at 95°C for 2 min followed by 40
cycles of 95°C for 15 s and 60°C for 1 min.

Vector Surveillance

Eight sites (1–8) were selected in Karachi for mosquito trap placement (Figure 2) based on their close vicinity to trees/shrubbery,
water, and human activity. The area was spread over 0.34 km2
and landscaped with high-rise buildings, lakes, water pools, and
intermittent green patches. The average distance between the sites
was 200 m.
Three types of mosquito traps were used including the CDC
Miniature Light Trap (Model 512), the BG-Sentinel™ (Biogents
GmbH, Regensburg, Germany) and the CDC Gravid trap (John
W. Hock Company, Gainesville, Florida, model 171). The traps
were set per manufacturers’ recommendations. The CDC light

Plaque Reduction Neutralization Testing
(PRNT)

A PRNT was performed to determine the neutralizing capacity
of patient serum. Viruses used included the following: WNV
(NY99), DENV-1 (TS-SMAN), DENV-2 (NGC), DENV-3
(H87), DENV-4 (H241), and JEV (SA-14-8). All PRNT assays
were performed side by side under BSL-3 containment to ensure

Figure 2 | Locations of the mosquito traps used for vector collection, May–November 2015. Sites were selected based on their close vicinity to trees/shrubbery,
water, and human activity. The area encompassed 0.34 km2 and included high-rise buildings, lakes, water pools, and green patches.
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trap was hung approximately 2 m above the ground. The BG
sentinel trap was baited with the BG-Lure attractant supplied by
the manufacturer and placed near an area sheltered from wind
and direct sunlight. The Gravid Trap infusion was prepared by
adding 3 l of water to dry grass hay. These traps were connected
to a 12 V rechargeable battery.
Mosquito surveillance activity began in May 2015 and ended
in November 2015. Traps were placed near identified locations for
four consecutive nights (Monday to Thursday) from 4:00 p.m. to
9:00 a.m. Each set of traps was placed at one site for 1 week and
then rotated to another site. The mosquitoes were collected daily
and taken directly to the research laboratory, and mosquitoes
were placed on a chilled Petri dish and separated and differentiated according to sex and species. Female mosquitoes species
were further separated according to blood and non-blood fed. All
identified mosquitoes were quantified and aliquoted and stored
at −80°. For each RT-PCR reaction, RNA was extracted from
individual pools of 30 mosquitoes. Mosquito grinding and RNA
extraction was performed using Qiagen viral RNA extraction kit.

dichotomous independent variables was performed. Odds ratios
were calculated with 95% confidence intervals. Ratios with a p
less than 0.05 were considered significant. Pearson’s correlation
coefficients, and associated p values were calculated to identify
potential relationships between different variables in the data set.

RESULTS
WNV Is a Cause of Febrile Illness in
Patients with Undifferentiated Fever in
Pakistan

West Nile virus exposed patients were enrolled from all five sites
beginning in May 2015 and continuing through December 2016
(Figure 3). Peaks in human case were observed during September
and October, which is consistent with the incidence of WNV
reported in other endemic areas like Europe, the United States,
and the Mediterranean region (Figure 3). Clinical specimens
were confirmed positive based on the CDC guidelines that require
detection of virus-specific IgM antibodies with virus-specific
neutralizing antibodies in the same or later specimen (23). Of
a total of 997 patients enrolled, based on the CDC criteria for
clinical manifestations of arboviral disease, 105 patients tested
positive for WNV IgM. Twenty-eight (26.6%) of these patients
were positive for WNV IgM only (Table S1 in Supplementary
Material). Seventy-nine (75.23%) patients exhibited positive IgM
for both WNV and JEV (Table S1 in Supplementary Material).
Eight (7.5%) of these patients were also positive for DENV NS1
antigen (Table S1 in Supplementary Material).
The 105 samples that were positive for WNV IgM were evaluated for neutralizing antibodies specific for JEV and WNV via
PRNT. Thirty-six (33.96%) exhibited greater neutralization for

Environment Monitoring of Temperature
and Humidity Charts

The Pakistan Meteorological Department, Karachi head-office
graciously shared their daily temperature, humidity, and precipitation monitoring data. Mean temperature, humidity, and
precipitation were calculated and recorded. Monthly data compilations were correlated with the number of mosquitoes collected
from traps and confirmed human WNV cases.

Statistical Analysis

Statistical analyses were performed on clinical data using
MedCalc version 17.9.7—64-bit. Logistic regression for

Figure 3 | Number of patients with both West Nile virus (WNV)-specific IgM and neutralizing antibodies. Data include patient specimens from all five study sites
over a 2-year period.
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WNV than JEV when the minimum neutralization was set at
80% (Table S1 in Supplementary Material). Fifty-nine (55.66%)
patients exhibited greater neutralization of WNV than JEV when
the minimum neutralization was decreased to 50% (Table S1 in
Supplementary Material). In the absence of neutralizing antibodies, patients were classified as probable exposures for the virus for
which they possessed the highest IgM activity. Seventeen (16.1%)
individuals had greater neutralizing activity for JEV than WNV
(Table S1 in Supplementary Material). Twenty-nine (27.36%)
patients did not exhibit significant neutralization of either WNV
or JEV (Table S1 in Supplementary Material). CSF samples from
two patients who presented with signs and symptoms suggestive
of viral encephalitis/meningitis were tested by RT-PCR for WNV;
however, none of the samples were positive for WNV (data not
shown).

neuroinvasive disease were not always indicative of WNV exposure. WNV confirmed individuals were 4.25 times more likely
to present with altered mental status (p = 0.0058) and twice as
likely to have seizures, hemorrhage, and encephalitis (Table 1).
Other symptoms of WNV neuroinvasive disease such as stiff
neck, vertigo, limb weakness, and reduced Glasgow Coma Scale
were not significant predictors of exposure and were just as
likely to be observed in individuals negative for WNV exposure
(Table 1). Over half of WNV-exposed individuals were younger
than 30 years, and 82% were younger than 40 years (Figure 4).
Although most patients with encephalitis were in the 20–30 age
group, the percentage of encephalitis was highest in the very
young or in the 50–60 and 60–70 age groups (Figure 4).
When comparing the symptoms of WNV- and JEV-exposed
individuals, several features were unique for each virus. Patients
with JEV exposure were 7.16 times more likely to present with
GI distress including nausea and vomiting (p = 0.0053) and 5.5
times more likely to be male (p = 0.0445; Table 2). Persons with
JEV exposure were also nearly five times more likely to exhibit
thrombocytopenia than WNV-exposed patients (p = 0.0438;
Table 2). However, altered mental status was not reported for
patients with JEV exposure and was 4.25 times more likely to be
identified in patients with WNV exposure (p = 0.043; Table 2).
Unfortunately, immune status ratios (ISRs) for the WNV
and JEV IgM kits did not correlate with neutralization via
PRNT (p = 0.76 WNV, p = 0.12 JEV; Table S1 in Supplementary
Material). Many WNV and JEV ISR values indicated positive
exposure, but the samples had little to no neutralizing activity
(Table S1 in Supplementary Material). Moreover, several WNV
ISR values indicated WNV exposure, but when assayed via
PRNT, these patients had greater neutralizing activity for JEV
than WNV (Table S1 in Supplementary Material). In the absence
of neutralizing antibodies, specimens were classified as suspect/

Clinical Features of Human WNV Infection

Of the 105 WNV IgM-positive patients, 61.9% were male (n = 65;
Table 1). The mean age was 31 years; however, patients from 10
to 86 were enrolled (data not shown). Clinical findings at time of
presentation included headache, body ache, and nausea/vomiting
and were seen in most patients enrolled. The average duration of
fever at time of presentation was 4 (±2) days. Thirty-nine (n = 41)
presented with signs and symptoms suggestive of central nervous
system (CNS) involvement that included altered consciousness,
vertigo, seizures, limb weakness, decreased Glasgow Coma
scores, and encephalitis (Table 1). For the sake of simplifying data
analysis, acute disseminated encephalomyelitis, meningitis, and
meningoencephalitis were all classified as encephalitis.
Although males comprised 73.5% of the WNV IgM positive
and 67% of the WNV confirmed population, this variable was
not significant (Table 1). Clinical symptoms suggestive of WNV

Table 1 | Incidence of symptoms of suspect and confirmed West Nile virus (WNV)-positive patients compared to WNV-negative patients presenting with clinical
features suggestive of arboviral disease.
Symptom

WNV confirmed (n)

WNV IgM+ (n)

WNV confirmed, OR (95% CI)

WNV suspect, OR (95% CI)

67% (40)
8.4% (5)
44% (26)
18.6% (11)
11.8% (7)
47.4% (28)
42.3% (25)
35% (21)
15% (9)
10.7% (6)
28.3% (17)
15% (9)
5% (3)
21.7% (13)
61.7% (37)
33.3% (20)
10.7% (6)
40.7% (24)
92.6% (25)
68.4% (26)

73.5% (64)
9% (8)
43.6% (38)
19.5% (17)
23.7% (14)
59.7% (52)
43.5% (38)
42.5% (37)
13.8% (12)
16% (14)
24% (21)
13.8% (12)
6.9% (6)
22.9% (20)
71.2% (62)
36.8% (32)
10.7% (9)
47.1% (41)
61% (63)
62.5% (42)

0.54 (0.22–1.31)
1.33 (0.30–5.87)
1.33 (0.61–2.90)
2.09 (0.68–6.44)
1.24 (0.44–3.52)
0.40 (0.18–0.89)
1.04 (0.48–2.28)
0.66 (0.30–1.45)
1.48 (0.46–4.75)
0.89 (0.29–2.68)
4.25 (1.32–13.69)
2.58 (0.66–10.14)
0.56 (0.12–2.65)
1.62 (0.62–4.24)
0.55 (0.23–1.31)
1.17 (0.52–2.65)
1.96 (0.48–8.06)
1.65 (0.75–3.62)
0.95 (0.80–1.12)
1.2 (0.47–3.34)

0.24 (0.05–1.13)
1.59 (0.18–13.79)
1.52 (0.55–4.25)
4.11 (0.51–33.12)
0.74 (0.21–2.56)
0.29 (0.09–0.95)
1.29 (0.46–3.61)
0.89 (0.33–2.46)
0.78 (0.19–3.13)
0.54 (0.15–1.93)
5.45 (0.68–43.44)
2.64 (0.32–21.79)
0.52 (0.09–2.93)
2.75 (0.59–12.88)
0.36 (0.09–1.34)
0.68 (0.24–1.87)
423E + 006
3.58 (1.10–11.66)
2.00 (0.49–8.24)
1.05 (0.83–1.13)

Male
Eye pain
Fever ≥ 38°C
Hemorrhage
Rash
Nausea
Headache
Myalgia
Arthralgia
Hypertension
Altered mental status
Seizures
Limb weakness
Encephalitis
Thrombocytopenia
Lymphocytosis
Reduced Glasgow Coma Scale
Any neurological symptom
Elevated AST
Elevated ALT

Patients with both WNV-specific IgM and neutralizing antibodies were considered confirmed, and patients with only IgM antibodies were considered suspect. Bold values indicate
statistical significance for the odds ratio (p < 0.05).
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probable exposure based on whichever virus exhibited the greatest ISR values.

positive for WNV, DENV, and JEV IgM. PRNTs were performed
for these patients against DENV 1-4, WNV, and JEV (Table S1
in Supplementary Material). All but three patients had at least
80% neutralizing activity against at least one DENV serotype at
antibody titers of 1:40 (Table S1 in Supplementary Material). Two
of the three non-DENV neutralizing patients did not exhibit neutralizing activity against WNV or JEV despite having encephalitis

WNV and JEV IgM Responses Are Highly
Cross-Reactive

A subset of 28 patients with JEV and WNV IgM antibodies were
evaluated for neutralization of DENV. These patients were all

Figure 4 | Continued
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Figure 4 | A graphical representation of how WNV infections (A), WNV encephalitis (B), and percentage of cases with neurological symptoms (C) occurred in
different age groups.
Table 2 | Incidence of symptoms in West Nile virus (WNV) and Japanese encephalitis virus (JEV) confirmed cases in patients presenting with clinical features
suggestive of arboviral disease.
Symptom
Male
Eye pain
Fever ≥ 38°C
Hemorrhage
Rash
Nausea
Headache
Myalgia
Arthralgia
Hypertension
Altered mental status
Seizures
Limb weakness
Encephalitis
Thrombocytopenia
Lymphocytosis
Reduced Glasgow Coma Scale
Any neurological symptom
Elevated AST
Elevated ALT
Dengue/WNV co-infection and neurological symptoms
Prior Dengue viruses exposure WNV neuroinvasive disease

WNV confirmed (n)

JEV confirmed (n)

WNV OR (95% CI)

JEV OR (95% CI)

67% (40)
8.4% (5)
44% (26)
18.6% (11)
11.8% (7)
47.4% (28)
42.3% (25)
35% (21)
15% (9)
10.7% (6)
28.3% (17)
15% (9)
5% (3)
21.7% (13)
61.7% (37)
33.3% (20)
33.3% (20)
40.7% (24)
10.7% (6)
40.7% (24)
14.8% (4)
11% (3)

94.4% (16)
5.9% (1)
35% (6)
5.9% (1)
23.5% (4)
94.4% (16)
41% (7)
41% (7)
11.8% (2)
17.6% (3)
0% (0)
0% (0)
11.8% (2)
5.9% (1)
94.4% (16)
41% (7)
0% (0)
41% (7)
71.4% (10)
73.3% (11)

0.54 (0.22–1.31)
1.33 (0.30–5.87)
1.33 (0.61–2.90)
2.09 (0.68–6.44)
1.24 (0.44–3.52)
0.40 (0.18–0.89)
1.04 (0.48–2.28)
0.66 (0.30–1.45)
1.48 (0.46–4.75)
0.89 (0.29–2.68)
4.25 (1.32–13.69)
2.58 (0.66–10.14)
0.56 (0.12–2.65)
1.62 (0.62–4.24)
0.55 (0.23–1.31)
1.17 (0.52–2.65)
1.65 (0.75–3.62)
0.95 (0.80–1.12)
1.2 (0.47–3.34)
0.79 (0.21–2.99)
2.16 (0.4–11.74)
0.18 (0.03–0.99)

3.5 (0.75–16.36)
0.73 (0.08–6.29)
0.82 (0.28–2.36)
0.28 (0.03–2.27)
1.6 (0.46–5.64)
7.16 (1.54–33.21)
0.72 (0.24–2.11)
1.06 (0.37–3.05)
0.84 (0.17–4.16)
1.36 (0.34–5.44)
7.68E–010
2.37E–009
0.85 (0.09–7.58)
0.19 (0.02–1.5)
3.94 (0.85–18.42)
1.4 (0.48–4.06)
2.40E–009
0.13 (0.03–0.62)
0.57 (0.14–2.31)
0.95 (0.74–1.22)

Patients with both virus-specific IgM and neutralizing antibodies were considered confirmed. For cross-reactive patients, exposure was confirmed for the virus with the greatest
Plaque Reduction Neutralization Testing titer. Bold values indicate statistical significance (p < 0.05).

and limb weakness and positive IgM antibodies (Table S1 in
Supplementary Material). The remaining patient had neutralizing antibodies to WNV only and presented with altered mental
status and meningitis. Sixteen of the 28 patients exhibited serological profiles indicative of prior DENV infections with DENV
Frontiers in Public Health | www.frontiersin.org

neutralization of at least 80% at the 1:2560 serum dilution (Table
S1 in Supplementary Material). Three of these patients exhibited
symptoms of neuroinvasive disease, but having prior exposure
to DENV was not a contributing factor (p = 0.0238; Table S1
in Supplementary Material). Here again, DENV ISR values did
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Figure 5 | Correlation of human West Nile virus cases, vector abundance, and average monthly temperatures in Karachi, Pakistan.

not correlate with neutralizing activity (p = 0.2931 DENV1,
p = 0.3157 DENV2, p = 0.4099 DENV3, p = 0.6602 DENV4)
nor were the ISR values dependent on whether the patient had a
primary or secondary DENV exposure (p = 0.9861; Table S1 in
Supplementary Material).

Table 3 | Numbers, species, and sex of mosquitoes caught in three types of
trap.

DENV/WNV Co-infections Are Associated
with Neurological Symptoms

Dengue virus NS1 antigen was detected in eight patients with
WNV-specific IgM and neutralizing antibodies. Four patients
exhibited symptoms of neuroinvasive disease and were twice
as likely to exhibit neurological symptoms than patients
without DENV co-infection (Table S1 in Supplementary
Material).

Genus

Male

Female

Total

CDC gravid
BG sentinel
CDC light
CDC gravid
BG sentinel
CDC light
CDC gravid
BG sentinel
CDC light

Culex
Culex
Culex
Anopheles
Anopheles
Anopheles
Aedes aegypti/Aedes albopictus
A. aegypti/A. albopictus
A. aegypti/A. albopictus

2,466
1,566
62
9
14
0
1
2
0

3,365
1,315
91
18
13
0
6
3
0

5,831
2,881
153
27
27
0
7
5
0

were subtracted from the analysis (r = 0.8067) (Figure 4). A total
of 8,931 mosquitoes were collected during the study period. The
majority of mosquitoes belonged to the Culex species (Table 3).
47.5% of the total number of mosquitoes were male Culex, while
female Culex represented 51.8% of the total (Table 3). Anopheles
(male 0.27%; female 0.34%) and Aedes (male 0.03%; female
0.097%) species accounted for very small percentages of the total
(Table 3). Mosquito numbers were lowest in the months of May
and June (n = 52); however, numbers increased significantly
during July (n = 984) and August (n = 1,110) with a peak in
September (n = 2,434) and October (n = 3,553; Figure 5). A
sharp decline in mosquito numbers was recorded in November
(n = 1,125; Figure 5). It was during the month of September that
WNV was detected in a pool of 30 Culex mosquitoes that were
trapped at location 8 (Figure 2), which is near the entrance to the
offices for the Aga Khan University Hospital.
Of the three types of traps used in this study, the CDC Gravid
Trap was the most successful in capturing Culex spp., catching
65.7% of all Culex spp. (Table 3). This was twice as effective as the

Vector Abundance Correlates with
Temperature and Precipitation

Temperature recordings for Karachi during 2015 showed an
increase in temperatures in May through October with average temperatures between 31 and 30°C. Peak temperatures
occurred in June (average = 33C°; Figure 5). During this
period, Karachi experienced the worst heat wave on record
for June with temperatures reaching 43°C. During this time,
significantly fewer mosquitoes were collected (Figure 5). The
average humidity showed an upward trend starting in May
that continued through October. During November, Karachi
experienced a fall in average temperatures by 3–4° and a drop
in relative humidity by 20% compared to the preceding months
(Figure 5).
The average number of mosquitoes collected in the traps correlated with peak temperatures of the city when the heat waves
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BG Sentinel and 38 times more effective than the CDC light Trap
(Table 3). For Anopheles and Aedes species, the CDC Gravid Trap
and the BG-Sentinel performed the same (Table 3). The CDC
Light Trap did not capture any Anopheles or Aedes species and
overall was the least successful, contributing only 2% to the total
number of mosquitoes caught (Table 3).

definitive diagnosis was not viewed as significant as it is growing to be. Emerging data documenting debilitating sequelae
including arthralgia and neurological issues, the development
of neurodegenerative disorders, and horrific congenital consequences emphasize the need for rapid and accurate diagnostics
to drive decisions and reassure patients and health care providers (26, 29–33).
Dengue viruses are endemic in Pakistan, and as such, many
patients enrolled in this study were diagnosed as having DENV
fever by physicians although neurological symptoms were present. It is not uncommon for DENV to co-circulate WNV and/
or JEV, which can lead to misdiagnosis as most of the symptoms
overlap. These viruses present as a flu-like illness characterized
by fever, myalgia, headache, gastrointestinal disturbance, and
maculopapular rash. Up to 1% of WNV-/JEV-infected individuals may show neuroinvasive disease (34, 35). Clinical features
like headache, altered mental status, GI distress, limb weakness,
and motor neuron disease pattern with flaccid paralysis are
clues to the diagnosis of CNS infection with WNV or JEV (34,
35). Over a third of WNV-confirmed patients here had clinical
features consistent with neuroinvasive disease. WNV-exposed
patients exhibited unique symptoms when compared to JEV.
WNV-infected individuals were much more likely to exhibit
altered mental status, reduced Glasgow Coma scores, encephalitis, and seizure activity, whereas persons with JEV infection
were more likely to suffer from nausea, thrombocytopenia, and
be male.
The data show that average summer temperatures correlated
with human WNV incidence. Mosquito numbers and human
WNV infections and precipitation were also directly correlated.
It was during this time that WNV was detected in a pool of Culex
spp., via RT-PCR, which suggests that active WNV transmission
was occurring. These findings are concordant with similar reports
in Europe (35, 36). The city of Karachi is an ideal urban environment for Culex spp. propagation and transmission. The city has
vectors, hosts, and an abundance of standing water with sewage or
other organic material that enhance larval propagation (37–39).
The low numbers of Aedes and Anopheles spp. collected was most
likely due to our trapping methods. No trapping occurred during the daytime when Aedes mosquitoes are active and CO2 or
other baits for attracting Anopheles were not used (40). Further
surveillance of larger geographical areas along with larval and
pupal demographic surveys are required to assess overall picture
of the various mosquito species in Karachi.
A major limitation of this study was that only patient serum
was tested via RT-PCR for the presence of virus. Since the inception of this study, research in molecular diagnostics of clinical
specimens has determined that whole blood and urine are more
useful for detecting WNV in human patients (41). Another
limitation of the study is that vector surveillance was conducted
in a small geographic region of Karachi (0.34 km2), and sentinel
animals were not used. Despite these limitations, our results can
be generalized as most of Karachi has similar features in terms of
mosquito propagation sites, avian fauna, and susceptible human
population.
Detection of vectors and humans infected with WNV is
suggestive of a competent enzootic cycle. The climatic and

DISCUSSION
Diagnosis and appropriate treatment of arboviral disease is problematic in areas where these pathogens co-circulate. Overlapping
clinical presentation combined with serological cross-reactivity render definitive diagnosis expensive and cumbersome.
Furthermore, secondary infections with these types of viruses
can exacerbate clinical symptoms and complicate interpretation
of diagnostic tests. Laboratory confirmation remains a major
challenge, and RT-PCR is not very useful in diagnosis of WNV
or JEV as viremia occurs 3–4 days before the onset of clinical
symptoms. Given that DENV, JEV, and WNV are flaviviruses,
there is serological cross-reactivity and absolute confirmation
requires the most cumbersome and highly skilled plaque reduction assay. This type of infrastructure is lacking in many labs and
medical facilities in Pakistan.
The data herein emphasize that viral IgM is not indicative of
exposure. Patients positive for JEV IgM were usually positive for
WNV IgM and vice versa. Even more troubling was that these
cross-reactive samples were also invariably positive for DENV
IgM (Table S1 in Supplementary Material). It was also impossible
to achieve a diagnosis based on the IgM activity alone as ISR
values were often very close in value and could not be directly
compared between viruses due to test composition and result
parameters. Analysis of the PRNT data showed no correlation
between IgM activity with neutralizing activity. There was also
no correlation between IgM positivity and PRNT positivity at any
serum dilution. As most of the epidemiological data being generated from lower- and middle-income countries is based on IgM
diagnostics, without further confirmatory testing or collection of
convalescent serum, this raises questions as to the true prevalence
for these viruses.
Similar diagnostic issues were present for neutralizing antibodies as most patients exhibited some level of neutralization for
WNV, JEV, and DENV 1–4. Similar neutralizing activity has been
reported for DENV and Zika virus, WNV and Murray Valley
encephalitis virus, JEV with DENV 1–4, and Yellow fever virus
with WNV, DENV, and tick-borne encephalitis virus (25–28). We
also noted a large background of prior DENV exposure indicated
via highly neutralizing PRNT titers, which mirrors what has been
reported in other studies examining flaviviral cross-reactivity
(26, 28).
When following the CDC/WHO diagnostic algorithms for
arboviral disease, cross-reactivity devalues their use if IgM
ELISA and PRNT are used as diagnostic tools. As stated by
Lee et al. “Prior to the introduction of Zika to the Americas,
PRNT was considered the gold standard of serological assays”
(26). Cross-reactive samples used to be diagnosed as “flavivirus
exposed” or some other generic classification. Since effective
treatments are not available for most flavivirus infections, a
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sanitation conditions in Karachi are supportive of active
propagation and dissemination of vectors and consequent risk
of an epidemic outbreak of this virus. Active disease surveillance and preventive strategies are not available in Pakistan
but are urgently needed at regional and national levels to
prevent such from happening in timely manner. Moreover,
there is as a great need for the standardization of diagnostic
assays and procedures, more accurate diagnostic assays,
and renovated diagnostic algorithms for Pakistan and other
countries where WNV co-circulates with other flaviviruses.
While development of surveillance networks, diagnostic
assays, and standardized procedures can be overwhelming for
developing countries, it is rapidly becoming apparent that the
long-term costs to public health are greater in the face of flavivirus disease. Given the high seroprevalence of flaviviruses,
reinstitution of DEWS or similar program should be seriously
considered for Pakistan.
Regardless, the findings of this study are an alert for physicians to suspect WNV infection in patients with altered mental
status and other neurological symptoms in a dengue-like illness
in patients inhabiting or traveling to and from Pakistan, especially
during the late summer and autumn months. WNV-associated
neuroinvasive disease is an important differential diagnosis for
other neurological diseases such as poliovirus currently circulating in Pakistan.
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